Cargando…

Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease

The aim was to analyze the infection, influencing factors, and clinical manifestations of Helicobacter pylori infection, coronary heart disease, and cytotoxin-associated protein A infection, so as to provide reference for the improvement of clinical diagnosis and treatment level of in-depth treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyuan, Du, Meiling, Li, Fangjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402355/
https://www.ncbi.nlm.nih.gov/pubmed/36072635
http://dx.doi.org/10.1155/2022/6814140
_version_ 1784773157217894400
author Wang, Xiaoyuan
Du, Meiling
Li, Fangjiang
author_facet Wang, Xiaoyuan
Du, Meiling
Li, Fangjiang
author_sort Wang, Xiaoyuan
collection PubMed
description The aim was to analyze the infection, influencing factors, and clinical manifestations of Helicobacter pylori infection, coronary heart disease, and cytotoxin-associated protein A infection, so as to provide reference for the improvement of clinical diagnosis and treatment level of in-depth treatment. This paper presents a clinical observation method based on Helicobacter pylori infection, risk factors, and cytotoxin-associated protein A in patients with coronary heart disease. Methods. 237 patients with CHD diagnosed and tested by 14C breath test were selected from inpatients of cardiovascular diseases in a hospital for retrospective analysis. The clinical data, serum deepening indicators, Hcy, and other factors were analyzed through general condition investigation, previous history investigation, and physical examination. The patients were observed by the SPSS22.0 statistical data processing method. The results showed that among the respondents, 175 cases were HP-positive, the infection rate was 73.8%, 77 patients with stable angina pectoris were 64.9%, and 160 patients with acute coronary heart disease were 78.1%. The difference between the groups was statistically significant (P < 0.05). Conclusion. Helicobacter pylori cytotoxic-associated protein A can increase the risk of gastric cancer, and Helicobacter pylori eradication treatment is more conducive to reduce the incidence of gastric cancer and ensure the safety of patients.
format Online
Article
Text
id pubmed-9402355
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94023552022-09-06 Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease Wang, Xiaoyuan Du, Meiling Li, Fangjiang Contrast Media Mol Imaging Research Article The aim was to analyze the infection, influencing factors, and clinical manifestations of Helicobacter pylori infection, coronary heart disease, and cytotoxin-associated protein A infection, so as to provide reference for the improvement of clinical diagnosis and treatment level of in-depth treatment. This paper presents a clinical observation method based on Helicobacter pylori infection, risk factors, and cytotoxin-associated protein A in patients with coronary heart disease. Methods. 237 patients with CHD diagnosed and tested by 14C breath test were selected from inpatients of cardiovascular diseases in a hospital for retrospective analysis. The clinical data, serum deepening indicators, Hcy, and other factors were analyzed through general condition investigation, previous history investigation, and physical examination. The patients were observed by the SPSS22.0 statistical data processing method. The results showed that among the respondents, 175 cases were HP-positive, the infection rate was 73.8%, 77 patients with stable angina pectoris were 64.9%, and 160 patients with acute coronary heart disease were 78.1%. The difference between the groups was statistically significant (P < 0.05). Conclusion. Helicobacter pylori cytotoxic-associated protein A can increase the risk of gastric cancer, and Helicobacter pylori eradication treatment is more conducive to reduce the incidence of gastric cancer and ensure the safety of patients. Hindawi 2022-08-17 /pmc/articles/PMC9402355/ /pubmed/36072635 http://dx.doi.org/10.1155/2022/6814140 Text en Copyright © 2022 Xiaoyuan Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Xiaoyuan
Du, Meiling
Li, Fangjiang
Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title_full Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title_fullStr Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title_full_unstemmed Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title_short Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease
title_sort clinical observation of helicobacter pylori infection and risk factors and cytotoxin-associated protein a in patients with coronary heart disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402355/
https://www.ncbi.nlm.nih.gov/pubmed/36072635
http://dx.doi.org/10.1155/2022/6814140
work_keys_str_mv AT wangxiaoyuan clinicalobservationofhelicobacterpyloriinfectionandriskfactorsandcytotoxinassociatedproteinainpatientswithcoronaryheartdisease
AT dumeiling clinicalobservationofhelicobacterpyloriinfectionandriskfactorsandcytotoxinassociatedproteinainpatientswithcoronaryheartdisease
AT lifangjiang clinicalobservationofhelicobacterpyloriinfectionandriskfactorsandcytotoxinassociatedproteinainpatientswithcoronaryheartdisease